Analysis Group Principal Howard Birnbaum Quoted on Opioid Crisis in The New Yorker

September 14, 2017

In an article titled "The Cost of the Opioid Crisis," the September 18, 2017 issue of The New Yorker cited Principal Howard Birnbaum's work on calculating the societal economic costs of prescription opioid abuse. Referring to a 2011 study published in Pain Medicine, the article noted that economic costs in the form of lost earnings and employment outstrip health care-related costs for treating abusers. "It's the old multiplier effect," Dr. Birnbaum points out. "The socioeconomic burden is much broader than on any individual or any firm."

Dr. Birnbaum is a coauthor with other Analysis Group colleagues and outside experts on a number of studies quantifying the economic burden of prescription opioid abuse, as well as on the cost savings and other impacts of abuse-deterrent opioids. His findings have been published widely and presented at major health care conferences over the past several years.

Read the article